Although a large-scale screening study of pancreatic cancers has identified CNTNAP2 as one of the genes that are methylated in cancer cells [34], the clinicopathological impact of DNA methylation of the CNTNAP2 gene has not yet been elucidated in human malignancies. This evidence concerns the gene CNTNAP2 and familial pancreatic carcinoma.